As the level of PD-1 expression on the T cells was reduced by methionine supplementation, a defect might have occurred in the methionine uptake efficiency of the T cells themselves or the extracellular methionine concentration might have decreased because of enhanced methionine use by the tumor. This evidence concerns the gene PDCD1 and neoplasm.